PRK director awarded 345 shares; direct holdings now 8,985
Park National Corp (PRK): Form 4 insider transaction.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Park National Corp (PRK): Form 4 insider transaction. Director F. W. Englefield IV reported an equity award of 345 common shares on 10/27/2025, coded “A” (grant/acquisition), at a stated price of $0. The award was made under the Park National Corporation 2017 Long‑Term Incentive Plan for Non‑Employee Directors.
Following the transaction, Englefield directly beneficially owns 8,985 common shares. Indirect holdings include 54 shares as Trustee of the Anthony J Englefield Trust and 53 shares as Trustee of the Janet Englefield Trust fbo Anthony J Englefield.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Shares | 345 | $0.00 | $0.00 |
| holding | Common Shares | -- | -- | -- |
| holding | Common Shares | -- | -- | -- |
Footnotes (1)
- F1. Common shares were awarded pursuant to and in accordance with the terms of the Park National Corporation 2017 Long-Term Incentive Plan for Non-Employee Directors (the "2017 Non-Employee Directors LTIP").
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did PRK disclose on this Form 4?
What was the transaction code and price for PRK?
Does the PRK director have indirect holdings?
What is the reporting person’s relationship to PRK?
AI-generated analysis. How Rhea-AI works. Not financial advice.